Legionella jordanis lower respiratory tract infection: case report and review.
Legionella jordanis was first described in 1982 after isolation from environmental sources and is otherwise a very rare human pathogen. Here, we report the recovery of L. jordanis from a bronchoalveolar lavage specimen from a patient who presented with an indolent lower respiratory tract infection associated with constitutional symptoms. This case is the first culture-positive case of infection involving this species in Canada.
Vinh
Donald C
DC
Department of Medical Microbiology, McGill University Health Centre, Montreal, Quebec, Canada.
Garceau
Richard
R
Martinez
Gabriela
G
Wiebe
Debbie
D
Burdz
Tamara
T
Reimer
Aleisha
A
Bernard
Kathryn
K
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use; D024841:Fluoroquinolones; D006801:Humans; D007875:Legionella / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification; D007876:Legionellosis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D000077266:Moxifloxacin; D011804:Quinolines / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin